Robert Negrin and Antony Letai
Mar 31, 2026, 16:03
Robert Negrin: Strengthening Collaboration with NCI to Advance Hematology Research
Robert Negrin, President of ASH, Professor at Stanford University, shared a post on LinkedIn:
“On behalf of the ASH leadership, thank you to Dr. Letai and NCI colleagues for meeting with us and sharing your vision and priorities for the Institute.
We also appreciated the opportunity to share details about ASH’s expanded efforts to support hematology research, promote the next generation of the hematology research workforce, and highlight other ASH programs.
We look forward to collaborating during this exciting time in science, while addressing some of the ongoing challenges we are seeing in research and clinical practice.
We look forward to seeing Dr. Letai at the annual meeting in New Orleans!”
Stay updated with Hemostasis Today.
-
May 24, 2026, 07:45Thierry Burnouf: Advances in Platelet Membrane-Coated Nanoparticles for Targeted Therapeutics and Regenerative Medicine
-
May 24, 2026, 07:39Shamala Thilarajah: Our Team Receives the NMRC Transition Award for NEUROACT-Stroke
-
May 24, 2026, 05:48Yazan Abou-Ismail: Contributing to the Future of von Willebrand Disease Management
-
May 24, 2026, 05:47Ali AlBahar: The Immunologic Complexity Behind ABO Blood Grouping
-
May 24, 2026, 05:46Ghaith Mansour: Honoring Scientific Collaboration at the 7th Pharmacy Research and Innovation Day
-
May 24, 2026, 04:57Ahmed Elsobky: Strengthening Hemophilia Care Under Egypt’s Universal Health Insurance System
-
May 24, 2026, 04:49Hussien Hishmat: There Is More to Pulmonary Embolism than Just Anticoagulation
-
May 24, 2026, 04:25Sarah Elkourashy: Diagnostic Challenges and Management Strategies for Maternal–Fetal Outcomes in TTP
-
May 24, 2026, 04:11Ayah Ghazi Al-Qasrawi: How Should Sepsis-Induced DIC Be Managed in Patients Receiving Thienopyridines